Beneficiaries who qualify under the expanded criteria will pay approximately 50 dollars per month for their GLP-1 medication, a dramatic reduction from the retail prices that have kept these drugs out of reach for many Medicare enrollees
Robust single-nucleus RNA sequencing reveals depot-specific cell population dynamics in adipose tissue remodeling during obesity
A systematic review of berberine trials found modest glucose-lowering effects, but the quality of evidence was generally low, and direct measurement of incretin hormones was rarely included
Gastric function parameters, including pepsinogen I (PGI), pepsinogen II (PGII), and gastrin 17 (G17), were assessed by chemiluminescent immunoassay (Maglumi, Shenzhen New Industries Biomedical Engineering Co., SNIBE, Shenzhen, China)